| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.0045 | 0.9 |